ColonPRO 4.0 (CPRO40.US)
Overview
Cosmo Artificial Intelligence – AI is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. They develop and manufacture innovative and high-quality products, partnering with global industry leaders and leading technology companies. Their mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Cosmo Artificial Intelligence – AI focuses on engineering technologies that support physicians in delivering high-quality care, complementing their clinical expertise through thoughtful innovation. Their work in AI and intelligent systems aims to improve detection, simplify workflows, and support more personalized care experiences.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-assisted colonoscopy
- Real-time polyp size estimation
- Comprehensive procedural highlights
- Enhanced algorithm for polyp detection
- Automated measurements of key quality metrics (inspection times, cecum detection, bowel cleanliness)
- Integration with GI Geniusu2122 platform
- Support for third-party applications via AI Accessu2122 platform
- Reduced false positives in polyp detection
Use Cases
- Assisting endoscopists in optimizing colonoscopy practice
- Improving detection of colorectal lesions (polyps/adenomas)
- Automating physician workflows and reducing administrative burdens in documentation
- Supporting internal programs on optimization of practices for healthcare organizations
- Guiding post-polypectomy surveillance intervals
- Expanding AI-assisted endoscopy beyond colorectal applications to other gastrointestinal indications
Details
| Category | Gastroenterology AI |
| Pricing | Unknown |
| Deployment | Hardware modules (GI Genius™ Module 100/200) with software (ColonPRO™ 4.0) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status |
Cleared AI-estimated ColonPRO™ 4.0 (CPRO40.US) received FDA clearance under K233964 on January 12, 2024, as a gastrointestinal lesion software detection system. It is part of the GI Genius™ intelligent endoscopy system, which was the first AI system to receive FDA clearance for the detection of colorectal polyps in 2021. |
| Integrations | |
| EHR | Not specified |
| Specialties | Colorectal Surgery, Gastroenterology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-01-12 | K233964 510(k) | ColonPRO 4.0 (CPRO40.US) |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate ColonPRO 4.0 (CPRO40.US)
Videos
Product demos, reviews, and walkthroughs for ColonPRO 4.0 (CPRO40.US).
No FAQs available yet for this tool.








